CC

Crescent Capital BDC, Inc.

CCAPFinancial ServicesNASDAQ

Asset Management · Last scanned Sep 9, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$47.4M
-43.2% YoY
Net Income
$34.5M
-53.1% YoY
Free Cash Flow
$49.7M

Scan Results

Daily timeframe
5 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 RSI OversoldRSI 15.9, below 30, stock may be oversold
Sep 1 RSI OversoldRSI 25.6, below 30, stock may be oversold
About Crescent Capital BDC, Inc.

Crescent Capital BDC, Inc. is as a business development company is a private debt fund. With a market capitalization of $379.1M, it sits in small-cap territory. It specializes in directly investing.

Where CCAP stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, CCAP finished 11.34% below its 150-day moving average ($11.73) and 14.05% below its 200-day moving average ($12.10). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is CCAP overbought or oversold?

At the September 3, 2026 close, CCAP's RSI(14) was 15.9, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$379.1M
Fwd P/E7.26
EPS$-0.09
Beta0.57
52W Change-33.5%
Dividend Yield14.66%
ROE-0.5%
Analysis

The company holds $15.6M in cash, though total debt stands at $926.0M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $49.7M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -0.5% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.6% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $23.2M to $47.4M.

The relatively low beta of 0.57 suggests CCAP is a less volatile holding compared to the broader index. Crescent Capital BDC, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Crescent Capital BDC, Inc.'s trajectory.

Links
More Financial Services stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms